LoginRegister
    FDA grants priority review to Roches Tecentriq monotherapy as first-line treatment in certain lung cancer casesFDA grants priority review to Roche's Tecentriq monotherapy as first-line treatment in certain lung...
    Primary healthcare can play key role in combating outbreaks like coronavirus: Biocon Chief Kiran Mazumdar-ShawPrimary healthcare can play key role in combating outbreaks like coronavirus: Biocon Chief Kiran...
    WuXi Biologics Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine LeaderWuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a...
    China offers tariff exemptions on US medical equipment amid virus outbreakChina offers tariff exemptions on US medical equipment amid virus outbreak
    Abbott introduces next-generation heart rhythm management devices in EuropeAbbott introduces next-generation heart rhythm management devices in Europe
    Sanofi joins forces with US Department of Health to advance a novel coronavirus vaccineSanofi joins forces with US Department of Health to advance a novel coronavirus vaccine
    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry GazetteDrug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette
    USFDA, Indian Government Join hands to clamp down on Illicit Medical ProductsUSFDA, Indian Government Join hands to clamp down on Illicit Medical Products
    Minister inaugurates Syngene new RnD centre in HyderabadMinister inaugurates Syngene new RnD centre in Hyderabad
    Govt approved Rs 1750 crore proposal for strengthening drug regulatory systemGovt approved Rs 1750 crore proposal for strengthening drug regulatory system
    Prices of Paracetamol surge by 40pc as coronavirus shuts ChinaPrices of Paracetamol surge by 40pc as coronavirus shuts China
    Marketing right for SGLT2 inhibitor Apleway to be transferred from Sanofi to KowaMarketing right for SGLT2 inhibitor Apleway to be transferred from Sanofi to Kowa
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X